Innovative AI Solutions For Decoding Biology System
Genes are syntax. Cells are apps. Cell-cell crosstalk makes up the operating system of biology. At CartaBio, we decode this complexity by using scalable single-cell technology and AI to precisely segment, target and correct cellular dysfunction—unlocking next-gen immune-modulating therapeutics.
“Carta Magna Of Cells” Platform
Revisiting The Northstar In Drug Discovery
Reductionists bet that drug discovery is a race to achieve the best-in-class modulation of target gene functions. This gene-centric oversimplification of diseases overlooks casual biological contexts and ultimately delays the inevitable disconnect with clinical success until later stages.
Is optimizing binding affinity akin to 'perfecting the batteries while forgetting that the ultimate goal is to fix a car'?
Welcome to Cell-Centric Solution
We believe in anchoring drug discovery through the lens of cellular intelligence, from target discovery to patient segmentation.
Leveraging patented single-cell technology and proprietary AI cell engine, we excel in identifying pathogenic cell states, intrinsic & extrinsic state-changing mechanisms, and the corresponding modulation at an unprecedented scale.
Meet the Team Driving Innovation
Drug R&D
Clinical Biology
Co-Founder & CEO
13 Yr In Pharma
Ex-JnJ, Celgene, Astrazeneca, Pfizer
WUSTL, Harvard, MIT
Clinical Biology
Clinical Biology
Co-founder & Board
Professor, Harvard
Center Director, Dept Chief, MGH
SAFE™ Spatial Tech Creator
Artificial Intelligence
Co-founder & AI Head
Winner of ‘21 NeurIPS Single-Cell Competition
CellBERT™ Cell AI Creator
Computational Biology
Artificial Intelligence
Artificial Intelligence
Artificial Intelligence
Artificial Intelligence
Drug R&D
Artificial Intelligence
Artificial Intelligence
And more...